Regulations/Legal

Latest Issue of OR Manager
January 2025
Home Regulations/Legal

Pfizer, BioNTech COVID-19 vaccine more than 90% effective, EUA application could come next week

Editor's Note Pfizer and BioNTech announced November 9 that their COVID-19 vaccine is more than 90% effective 7 days after the second dose in preventing COVID-19 infection in participants without evidence of prior infection. This means that protection is achieved 28 days after initiation of the vaccination, which consists of…

Read More

By: Judy Mathias
November 9, 2020
Share

CMS: How to prepare for COVID-19 vaccine

Editor's Note The Centers for Medicare and Medicaid Services (CMS) on November 5 released a set of toolkits and enrollment actions to take to administer the COVID-19 vaccine when it’s available. Many Medicare-enrolled providers don’t have to take any actions until the vaccine is available. Some Medicare-enrolled providers must also…

Read More

By: Judy Mathias
November 5, 2020
Share

CDC: Birth, infant outcomes after COVID-19 in pregnancy

Editor's Note In this analysis of COVID-19 data from the Centers for Disease Control and Prevention, the proportion of preterm live births in women with COVID-19 infection during pregnancy was higher than that in the general population in 2019, suggesting that pregnant women with COVID-19 infection might be at risk…

Read More

By: Judy Mathias
November 5, 2020
Share

FDA alerts providers on how to prevent false positive results with COVID-19 antigen tests

Editor's Note The Food and Drug Administration (FDA) on November 3 issued a letter alerting clinical laboratory staff and healthcare providers that false positive results can occur with antigen tests, including when users do not follow instructions for use of antigen tests for the rapid detection of COVID-19. Among the…

Read More

By: Judy Mathias
November 5, 2020
Share

Sponsored Message

J&J to test COVID-19 vaccine in adolescents

Editor's Note Johnson & Johnson (J&J) has announced plans to test their COVID-19 vaccine in young individuals between the ages of 12 and 18, the October 30 Reuters reports. J&J started testing its vaccine in 60,000 volunteer adults in late September. Depending on safety, J&J also plans to test the…

Read More

By: Judy Mathias
November 4, 2020
Share

CMS penalizes 2,545 hospitals for high readmissions

Editor's Note The Centers for Medicare and Medicaid Services (CMS) will penalize and reduce a year’s worth of payments to nearly half of the nation’s hospitals because of 30-day readmission rates, the November 2 Kaiser Health News reports. The penalties are part of the ninth year of the Hospital Readmissions…

Read More

By: Judy Mathias
November 3, 2020
Share

Sponsored Message

Effect of elective surgery cancellation on ICU capacity in New York State

Editor's Note Suspension of elective surgical procedures in response to the COVID-19 pandemic in New York State had only a minor effect on ICU capacity, this study finds. State authorities suspended all elective surgical procedures in mid-March 2020 to increase hospital and ICU bed capacity. However, the effect of canceling…

Read More

By: Judy Mathias
November 2, 2020
Share

CMS issues coverage plan for COVID-19 vaccines, treatments

Editor's Note The Centers for Medicare and Medicaid Services (CMS) on October 28 issued an interim final rule that requires CMS to cover any COVID-19 vaccines that receive Food and Drug Administration (FDA) authorization at no cost to beneficiaries. The rule also will increase what Medicare pays hospitals for COVID-19…

Read More

By: Judy Mathias
October 29, 2020
Share

Association of stay-at-home orders and state-level rates of African American’s with COVID-19

Editor's Note A state’s stay-at-home orders (SAHOs) were associated with reductions in COVID-19 cases and fatality rates between March and May 2020, and a state’s number of African Americans was associated with more COVID-19 cases and fatalities in this study from the University of Alabama at Birmingham. Of 3,023 pooled…

Read More

By: Judy Mathias
October 29, 2020
Share

Joint Commission deletes EP on flu vaccination goal

Editor's Note The Joint Commission on October 28 announced that beginning January 1, 2021, it is eliminating the element of performance (EP) for Infection Control Standard IC.02.04.01, which sets incremental influenza vaccination goals to try and achieve the 90% rate set by national initiatives. The US Department of Health and…

Read More

By: Judy Mathias
October 29, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat